H Robert Superko

Summary

Publications

  1. ncbi request reprint Lipoprotein subclasses and atherosclerosis
    R H Superko
    Berkeley HeartLab, Cholesterol, Genetics and Heart Disease Institute, 1875 South Grant St, San Mateo, CA 94402, USA
    Front Biosci 6:D355-65. 2001
  2. ncbi request reprint Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification
    H R Superko
    Berkeley HeartLab, University of California, Berkeley, California 94010, USA
    Am J Cardiol 88:260-4. 2001
  3. ncbi request reprint Small LDL and its clinical importance as a new CAD risk factor: a female case study
    H Robert Superko
    Advanced Cardiovascular Prevention Program, American Cardiovascular Research Institute, Atlanta, GA 30342, USA
    Prog Cardiovasc Nurs 17:167-73. 2002
  4. ncbi request reprint Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals
    H Robert Superko
    Berkeley HeartLab, Inc, Burlingame, CA 94010, USA
    Am Heart Hosp J 1:135-40. 2003
  5. doi request reprint Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia
    H Robert Superko
    Saint Joseph s Translational Research Institute, Atlanta, GA, USA
    Am J Cardiol 103:387-92. 2009
  6. doi request reprint High-density lipoprotein subclasses and their relationship to cardiovascular disease
    H Robert Superko
    Mercer University School of Pharmacy Sciences, Atlanta, GA, USA
    J Clin Lipidol 6:496-523. 2012
  7. doi request reprint Firefighters, heart disease, and aspects of insulin resistance: the FEMA Firefighter Heart Disease Prevention study
    H Robert Superko
    Saint Josephs Research Institute, Mercer University School of Pharmaceutical Sciences, Atlanta, Georgia, USA
    J Occup Environ Med 53:758-64. 2011
  8. doi request reprint Family coronary heart disease: a call to action
    H Robert Superko
    Center for Genomics and Human Health, Saint Joseph s Translational Research Institute, Atlanta, Georgia, USA
    Clin Cardiol 33:E1-6. 2010
  9. ncbi request reprint Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A
    H Robert Superko
    Fuqua Heart Center Piedmont Hospital, Atlanta, Georgia, USA
    Am J Cardiol 96:1266-72. 2005
  10. doi request reprint Lipid management to reduce cardiovascular risk: a new strategy is required
    H Robert Superko
    Center for Genomics and Human Health, St Joseph s Translational Research Institute, 5673 Peachtree Dunwoody Rd NE, Ste 675, Atlanta, GA 30342, USA
    Circulation 117:560-8; discussion 568. 2008

Detail Information

Publications15

  1. ncbi request reprint Lipoprotein subclasses and atherosclerosis
    R H Superko
    Berkeley HeartLab, Cholesterol, Genetics and Heart Disease Institute, 1875 South Grant St, San Mateo, CA 94402, USA
    Front Biosci 6:D355-65. 2001
    ..Individual patient information regarding LDL and HDL subclass distribution can be used to improve medical management of the CAD patient that results in improved outcomes...
  2. ncbi request reprint Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification
    H R Superko
    Berkeley HeartLab, University of California, Berkeley, California 94010, USA
    Am J Cardiol 88:260-4. 2001
    ....
  3. ncbi request reprint Small LDL and its clinical importance as a new CAD risk factor: a female case study
    H Robert Superko
    Advanced Cardiovascular Prevention Program, American Cardiovascular Research Institute, Atlanta, GA 30342, USA
    Prog Cardiovasc Nurs 17:167-73. 2002
    ..Often the most effective interventions are the least expensive...
  4. ncbi request reprint Sophisticated tests for susceptibility to atherosclerosis: an added value for heart hospitals
    H Robert Superko
    Berkeley HeartLab, Inc, Burlingame, CA 94010, USA
    Am Heart Hosp J 1:135-40. 2003
    ..Incorporation of such a clinical service is consistent with the recent American College of Cardiology focus on the "CardioTeam."..
  5. doi request reprint Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia
    H Robert Superko
    Saint Joseph s Translational Research Institute, Atlanta, GA, USA
    Am J Cardiol 103:387-92. 2009
    ..In conclusion, this investigation revealed that a combination of a fibric acid derivative and nicotinic acid offers greater improvement in detailed lipoprotein subclass distribution and apolipoprotein ratios than monotherapy...
  6. doi request reprint High-density lipoprotein subclasses and their relationship to cardiovascular disease
    H Robert Superko
    Mercer University School of Pharmacy Sciences, Atlanta, GA, USA
    J Clin Lipidol 6:496-523. 2012
    ..To assess the clinical utility of measuring high-density lipoprotein (HDL) subfractions to assess coronary heart disease (CHD) risk...
  7. doi request reprint Firefighters, heart disease, and aspects of insulin resistance: the FEMA Firefighter Heart Disease Prevention study
    H Robert Superko
    Saint Josephs Research Institute, Mercer University School of Pharmaceutical Sciences, Atlanta, Georgia, USA
    J Occup Environ Med 53:758-64. 2011
    ..To determine the association of cardiovascular risk markers with noninvasive imaging of atherosclerosis in firefighters...
  8. doi request reprint Family coronary heart disease: a call to action
    H Robert Superko
    Center for Genomics and Human Health, Saint Joseph s Translational Research Institute, Atlanta, Georgia, USA
    Clin Cardiol 33:E1-6. 2010
    ..For clinicians, the question is how to utilize this information, in an efficient manner, in order to improve patient care and detection of high-risk family members...
  9. ncbi request reprint Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A
    H Robert Superko
    Fuqua Heart Center Piedmont Hospital, Atlanta, Georgia, USA
    Am J Cardiol 96:1266-72. 2005
    ..Thus, treatment with gemfibrozil may have additional antiatherogenic effects in those with LDL pattern B by decreasing small dense LDL that is not apparent in those with pattern A...
  10. doi request reprint Lipid management to reduce cardiovascular risk: a new strategy is required
    H Robert Superko
    Center for Genomics and Human Health, St Joseph s Translational Research Institute, 5673 Peachtree Dunwoody Rd NE, Ste 675, Atlanta, GA 30342, USA
    Circulation 117:560-8; discussion 568. 2008
  11. ncbi request reprint Is it LDL particle size or number that correlates with risk for cardiovascular disease?
    H Robert Superko
    Center for Genomics and Human Health, Saint Joseph s Translational Research Institute, 5673 Peachtree Dunwoody Road NE, Suite 675, Atlanta, GA 30342, USA
    Curr Atheroscler Rep 10:377-85. 2008
    ..LDL particle size and number provide independent measures of atherogenicity and are strong predictors of CVD...
  12. ncbi request reprint High-density lipoprotein subclass distribution in individuals of Asian Indian descent: the National Asian Indian Heart Disease Project
    H Robert Superko
    Molecular, Genetic, and Preventive Cardiology, Fuqua Heart Center Piedmont Medical Center, Atlanta, GA 30309, USA
    Prev Cardiol 8:81-6. 2005
    ..Low high-density lipoprotein 2b combined with the higher lipoprotein(a) in the Asian Indian group may help explain the high prevalence of coronary artery disease in this ethnic population...
  13. doi request reprint Statins personalized
    H Robert Superko
    Celera Corporation, Alameda, CA 94502, USA
    Med Clin North Am 96:123-39. 2012
    ..A large portion of the individual response to statin therapy is attributed to single nucleotide polymorphisms that have recently been elucidated, several of which seem to have clinical utility...
  14. ncbi request reprint Smallest LDL particles are most strongly related to coronary disease progression in men
    Paul T Williams
    Life Sciences Division, E O Lawrence Berkeley National Laboratory, University of California, Berkeley, USA
    Arterioscler Thromb Vasc Biol 23:314-21. 2003
    ..2 to 24.7 nm), LDL-IVa (23.3 to 24.2 nm), and LDL-IVb (22.0 to 23.3 nm in diameter). We hypothesized that the association between smaller LDL particles and coronary artery disease (CAD) risk might involve specific LDL subclasses...
  15. ncbi request reprint Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I
    H Robert Superko
    Fuqua Center for Prevention, Fuqua Heart Center Piedmont Hospital, Atlanta, Georgia USA
    Am J Cardiol 94:588-94. 2004
    ..Nicotinic acid has a significantly greater effect on the decrease of small LDL subclass distribution and increase in LDL peak particle diameter in pattern B versus pattern A...